Stock Analysis of PHAT ( Phathom Pharmaceuticals, Inc. )

STOCK RANK

The Stock Rank is a quick snapshot of a stock’s potential, based on key financial ratios in four areas: Quality, Value, Growth, and Momentum. You can explore detailed insights below for each category.

Stock Rank

QUALITY

ROA-48.71%

ROIC-44.83%

Debt/Equity-2.77

Current Ratio5.73

Operating Margin-24532.55%

VALUE

Price/Book-3.19

Earnings Yield-56.86%

EV/EBITDA-1.65

Price/Sales22.72

Dividend Yield0.0%

GROWTH

Asset 1-Year Growth151.1%

EPS 1-Year Growth-177.82%

Revenue Average Growth (3-Year)-

Revenue 1-Year Growth-

EBITDA Average Growth (3-Year)-210.69%

MOMENTUM

1-Week Return-8.3%

1-Month Return-45.71%

3-Month Return-32.27%

6-Month Return-17.17%

12-Month Return17.81%

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

For more details on short-term price trend, check out technical analysis of PHAT

Discover additional signals and ratios for Quality, Value, Growth, and Momentum. To integrate these factors into your own spreadsheets or software, access Signal DB here.

For building multi-factor portfolios, explore our Portfolio Toolbox .

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.